Crossmark

Differentiating Ischemic Hepatitis from Acetaminophen Overdose in Acute Liver Failure: Role of Acetaminophen Adducts—Ischemic Hepatitis vs Acetaminophen Overdose

Crossref DOI link: https://doi.org/10.1007/s10620-024-08602-7

Published Online: 2024-09-02

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rule, Jody A.

Ajayi, Faith

James, Laura P.

Tujios, Shannan R.

Sussman, Norman L.

Rakela, Jorge L.

Ganger, Daniel

Bass, Norman L.

Reuben, Adrian

Stravitz, R. Todd

Lee, William M.

,
License Information

Text and Data Mining valid from 2024-09-02

Version of Record valid from 2024-09-02
More Information

Article History

Received: 15 May 2024

Accepted: 18 August 2024

First Online: 2 September 2024

Declarations

:

: WML consults for Genentech, SeaGen, GSK and Veristat and receives research support from Gilead, Alexion, Vivet, Camurus, Lipocine, Madrigal and Akero, none related to the current article. LPJ is a part owner of Acetaminophen Toxicity Diagnostics and has submitted a patent for Acetastat®. NLS is employed by Durect but has no conflict with the current article. The remaining authors have no conflict.

Document is current

Any future updates will be listed below